Nasopharyngeal carcinoma progression is mediated by EBER-triggered inflammation via the RIG-I pathway.
第一作者:
Yumei,Duan
第一单位:
Center for Molecular Medicine, Xiangya Hospital, Central South University, Changsha 410008, China; The department of pathology of Xiangya Hospital, Central South University, Changsha 410008, China.
作者:
主题词
动物(Animals);印迹法, 蛋白质(Blotting, Western);癌(Carcinoma);细胞分化(Cell Differentiation);共同培养技术(Coculture Techniques);细胞因子类(Cytokines);DEAD-box RNA解旋酶类(DEAD-box RNA Helicases);疾病恶化(Disease Progression);女(雌)性(Female);人类(Humans);免疫酶技术(Immunoenzyme Techniques);免疫沉淀法(Immunoprecipitation);炎症(Inflammation);炎症介导素类(Inflammation Mediators);干扰素调节因子3(Interferon Regulatory Factor-3);巨噬细胞(Macrophages);小鼠(Mice);小鼠, 近交BALB C(Mice, Inbred BALB C);小鼠, 裸(Mice, Nude);NF-κB(NF-kappa B);鼻咽肿瘤(Nasopharyngeal Neoplasms);RNA, 信使(RNA, Messenger);RNA, 小分子干扰(RNA, Small Interfering);RNA, 病毒(RNA, Viral);受体, 免疫(Receptors, Immunologic);逆转录聚合酶链反应(Reverse Transcriptase Polymerase Chain Reaction);肿瘤细胞, 培养的(Tumor Cells, Cultured);肿瘤微环境(Tumor Microenvironment);异种移植模型抗肿瘤试验(Xenograft Model Antitumor Assays)
DOI
10.1016/j.canlet.2015.02.037
PMID
25721089
发布时间
2023-12-13
- 浏览65

Cancer letters
67-74页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文